A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B ...

Rituximab and ocrelizumab go head to head in randomized trial ...

Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...

A lab study suggests cyclodextrins may help support myelin sheath repair in MS by reducing harmful fat buildup in immune cells.

Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.

Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...

Multiple sclerosis occurs when a person’s immune system is triggered to attack the myelin sheath—a protective coating surrounding nerve cells in the central nervous system (CNS). The CNS is made up of ...

India, June 28 -- Multiple sclerosis (MS) affects much more than physical health, often disrupting people's social lives, ...

Sponsored by Novartis Jamie Lynn Sigler opens up about self-advocacy, finding her treatment plan and why your voice should be the loudest in the room when it comes to your health.

A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a low ...